일본의 원격 환자 모니터링 시장(2025-2033년)

The Japan remote patient monitoring market reached US$ 470.56 million in 2024 and is expected to reach US$ 3,536.54 million by 2033, growing at a CAGR of 24.9% during the forecast period 2025-2033.

Remote Patient Monitoring (RPM) is a healthcare practice that uses digital technologies to collect medical data from patients outside traditional settings, enabling doctors to track vital signs in real time or periodically. This technology is particularly beneficial for patients with chronic conditions, elderly individuals, or post-operative care, as it allows timely interventions and reduces hospital visits. RPM enhances patient care, improves health outcomes, and promotes convenience by allowing continuous monitoring without physically present patients in a healthcare facility.

Market Dynamics: Drivers & Restraints

Technological Advancements and Increasing Adoption of Wearable Devices

The Japan remote patient monitoring (RPM) market is driven by advancements in healthcare technology and the growing use of wearable health devices. These devices track real-time health parameters, improving accuracy and efficiency. They are integrated with smartphone applications and cloud platforms, promoting proactive patient management. This technological evolution has increased patient acceptance and encouraged healthcare providers to incorporate RPM into their practices. Generally, elderly or chronic disease patients are the target population for remote patient monitoring devices; however, in Japan, several companies are coming up with innovations to track the health and wellness of all types of patients.

For instance, a Japan-based company, MEDIROM Healthcare technologies Inc., has recently become popular with the launch of its innovation, the "MOTHER Bracelet", a charging-free smart health tracker that is integrated with REMONY, a remote health monitoring system. In January 2025, the company collaborated with the Electronics Division of TOPPAN Inc. to provide these advanced monitoring devices. TOPPAN plans to use these devices, the MOTHER Bracelet and REMONY, for the health monitoring of its employees and aims to establish an environment that enables early detection and prompt responses in the event of certain health abnormalities.

Data Privacy and Security Concerns

The Japanese remote patient monitoring (RPM) market faces significant challenges due to concerns over data privacy and security. RPM systems collect and transmit sensitive patient health data, and any breach can lead to unauthorized access. Strict data protection regulations and fear of security vulnerabilities discourage patients and healthcare providers from fully adopting RPM solutions, hindering market growth.

Segment Analysis

The Japan remote patient monitoring market is segmented based on device type, application, and end user.

Device Type:

Wearable Devices in the device type segment are expected to dominate with the highest market share.

Japan's remote patient monitoring (RPM) market is thriving due to wearable devices that enable real-time health tracking, early disease detection, and continuous management of chronic conditions. These devices collect vital health data, such as heart rate, blood pressure, oxygen levels, and glucose levels. The integration of AI and IoT in wearable technology improves data analysis, reduces hospital visits, and enhances patient engagement, particularly in Japan's aging population and increasing demand for home-based care. Several innovative wearable devices are being launched in the Japanese market, which can significantly tap the areas with high unmet needs.

For instance, in September 2024, iRhythm Technologies, Inc. announced that the Japanese Pharmaceutical and Medical Device Agency (PMDA) has approved Zio fourteen-day, long-term continuous ECG monitoring system. Zio is a wearable device supported with ZEUS - Zio ECG Utilization Software System and iRhythm's advanced AI algorithm, and can be used in the early diagnosis of cardiac arrhythmias.

Competitive Landscape

The major country players in the remote patient monitoring market include Nihon Kohden Corporation, OMRON Healthcare Co., Ltd Terumo Corporation, Fukuda Denshi Co., Ltd, Panasonic Healthcare Co., Ltd., Sharp Corporation (Healthcare Devices Division), Medirom Healthcare Technologies Inc, A&D Company, Limited, HealthNode, Medical Edge Co Ltd and among others.

Key Developments

• In April 2024, OMRON Healthcare Co., Ltd. acquired Luscii Healthtech, a rapidly growing digital health and remote consultation service platform. Since OMRON's seed investment in 2018, the two companies have collaborated on digital health development. Luscii, a pioneer in smart remote care and virtual wards, has a unique culture for innovation and an agile philosophy, enabling them to address the complex demands of healthcare systems.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Country's Growth & Investment: Highlights high-growth countries and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Remote Patient Monitoring market report delivers a detailed analysis with 72 key tables, more than 67 visually impactful figures, and 210 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Speciality Area & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Device Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Country

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Technological Advancements and Increasing Adoption of Wearable Devices
  • 4.1.2. Restraints
    • 4.1.2.1. Data Privacy and Security Concerns
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Device Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 6.1.2. Market Attractiveness Index, By Device Type
• 6.2. Wearable Devices*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Non-Wearable Devices

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Chronic Disease Management*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Post-Operative Care
• 7.4. Maternal Health
• 7.5. Mental Health
• 7.6. Emergency Care
• 7.7. General Health and Wellness
• 7.8. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Homecare Settings
• 8.4. Others

9. Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

• 10.1. Nihon Kohden Corporation*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio
    • 10.1.2.1. Product Description
    • 10.1.2.2. Product Key Performance Indicators (KPIs)
    • 10.1.2.3. Historic and Forecasted Product Sales
    • 10.1.2.4. Product Sales Volume
  • 10.1.3. Financial Overview
    • 10.1.3.1. Company Revenue's
    • 10.1.3.2. Geographical Revenue Shares
    • 10.1.3.3. Revenue Forecasts
  • 10.1.4. Key Developments
    • 10.1.4.1. Mergers & Acquisitions
    • 10.1.4.2. Key Product Development Activities
    • 10.1.4.3. Regulatory Approvals, etc.
  • 10.1.5. SWOT Analysis
• 10.2. OMRON Healthcare Co., Ltd.
• 10.3. Terumo Corporation
• 10.4. Fukuda Denshi Co., Ltd.
• 10.5. Panasonic Healthcare Co., Ltd.
• 10.6. Sharp Corporation (Healthcare Devices Division)
• 10.7. Medirom Healthcare Technologies Inc
• 10.8. A&D Company, Limited
• 10.9. HealthNode
• 10.10. Medical Edge Co Ltd
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

11. Appendix

• 11.1 About Us and Services
• 11.2 Contact Us